Request a document copy: Durable Clinical Efficacy of Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study)

all files (of this document) in restricted access
the file(s) you requested
Cancel